Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Journal of Visualized Experiments · 2026
DOI: 10.3791/70693 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2026. Written by Alexia de Matos Czeczot and 9 co-authors. Institution: Center for Molecular and Functional Biology Research, National Institute of Science and Technology in Tuberculosis, Pontifical Catholic University of…. Major MEDLINE topics: Antitubercular Agents, Mycobacterium tuberculosis. 17 references.
Abstract (original language)
Tuberculosis (TB) remains one of the leading causes of death from a single infectious agent worldwide, with rising rates of drug resistance making the development of novel therapeutic agents a global health priority. This protocol describes a phenotypic screening approach for identifying potential anti-TB drug candidates through three integrated stages. First, a compound from the 4-aminoquinoline class is synthesized via a three-step route and fully characterized by high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectroscopy, and high-resolution mass spectrometry (HRMS). Second, the antimicrobial activity of the compound is evaluated against Mycobacterium tuberculosis using the colorimetric resazurin reduction microplate assay (REMA), which determines the minimum inhibitory concentration (MIC) through a simple visual color-change readout. Third, the compound's cytotoxicity is assessed in two mammalian cell lines, Vero (African green monkey kidney) and HepG2 (human hepatocellular carcinoma), using the MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) and the neutral red uptake (NRU) assay. These two complementary assays measure distinct cellular parameters, enabling cross-validation of cytotoxicity results. Together, the MIC and cytotoxicity data allow calculation of a selectivity index (SI) to assess the therapeutic potential of each compound. This protocol provides a reproducible, step-by-step framework for early-stage anti-TB hit identification and preclinical evaluation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Center for Molecular and Functional Biology Research, National Institute of Science and Technology in Tuberculosis, Pontifical Catholic University of Rio Grande do Sul; Graduate Program in Cellular and Molecular Biology…
- Center for Molecular and Functional Biology Research, National Institute of Science and Technology in Tuberculosis, Pontifical Catholic University of Rio Grande do Sul.
Cite
APA
de Matos Czeczot, A., Maia, A. M., Zotti, C. Z., Gonçalves, G. A., Delgado da Paz, J., Perelló, M. A., Roth, N. K., Basso, L. A., Machado, P., & Bizarro, C. V. (2026). Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells. Journal of Visualized Experiments. https://doi.org/10.3791/70693
Vancouver
de Matos Czeczot A, Maia AM, Zotti CZ, Gonçalves GA, Delgado da Paz J, Perelló MA, et al. Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells. Journal of Visualized Experiments. 2026. doi:10.3791/70693
BibTeX
@article{deMatosCzeczot2026,
author = {de Matos Czeczot, Alexia and Maia, Ariel Moura and Zotti, Camili Zanella and Gonçalves, Guilherme Arraché and Delgado da Paz, Josiane and Perelló, Marcia Alberton and Roth, Nicholas Kraether and Basso, Luiz Augusto and Machado, Pablo and Bizarro, Cristiano Valim},
title = {Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells},
journal = {Journal of Visualized Experiments},
year = {2026},
doi = {10.3791/70693}
}
EUVIMED